ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients

被引：0
|
作者：
Daoud, Ahmed [1 ]
Ali, Hatem [2 ]
Rao, Vinaya [3 ]
Rohan, Vinayak [4 ]
Soliman, Karim [3 ]
机构：
[1] Cairo Univ, Kasr Alainy Fac Med, Dept Internal Med, Cairo, Egypt
[2] Univ Hosp Coventry & Warwickshire NHS Trust, Dept Internal Med, Internal Med, Coventry, W Midlands, England
[3] Med Univ South Carolina, Dept Internal Med, Charleston, SC USA
[4] Med Univ South Carolina, Dept Surg, Charleston, SC USA
来源：
RENAL FAILURE | 2021年 / 43卷 / 01期
关键词：
RISK-FACTORS;
D O I：
10.1080/0886022X.2021.1994419
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1463 / 1464
页数：2
相关论文
共 50 条
  • [21] The Use Of Ace Inhibitors And Angiotensin Receptor Blockers Is Associated With Decreased Mortality And Increased Hospitalization Rate In Covid-19 Patients
    Douen, Aaron
    Oh, Jeremy
    Romney, Wesley
    Panetti, Ryan
    Ramdass, Prakash
    Toreli, Aleksandre
    Juang, George
    HYPERTENSION, 2021, 78
  • [22] In-hospital use of ACE inhibitors/angiotensin receptor blockers associates with COVID-19 outcomes in African American patients
    Li, Shilong
    Sarangarajan, Rangaprasad
    Jun, Tomi
    Kao, Yu-Han
    Wang, Zichen
    Hao, Ke
    Schadt, Emilio
    Kiebish, Michael A.
    Granger, Elder
    Narain, Niven R.
    Chen, Rong
    Schadt, Eric E.
    Li, Li
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (19):
  • [23] Effect of ACE inhibitors and angiotensin receptor blockers on in-hospital mortality and length of stay in hospitalized COVID-19 patients
    LaClair, Heather J.
    Khosrodad, Nadia
    Sule, Anupam A.
    Koehler, Tracy
    Krishnamoorthy, Geetha
    VASCULAR PHARMACOLOGY, 2021, 141
  • [24] Association of ACE2 receptor and ACEIs/ARBs with disease severity in COVID-19
    Sinha, Shweta
    Sehgal, Alka
    Sehgal, Rakesh
    DRUG DISCOVERIES AND THERAPEUTICS, 2020, 14 (04): : 161 - 170
  • [25] ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19
    Wang, Yueying
    Tse, Gary
    Li, Guangping
    Lip, Gregory Y. H.
    Liu, Tong
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (17) : 2041 - 2041
  • [26] Angioedema, ACE inhibitor and COVID-19
    Grewal, Ekjot
    Sutarjono, Bayu
    Mohammed, Ibbad
    BMJ CASE REPORTS, 2020, 13 (09)
  • [27] Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) may be safe for COVID-19 patients
    Wang, Wenjun
    Zhao, Xiaohui
    Wei, Wei
    Fan, Weiwang
    Gao, Kai
    He, Shengxiu
    Zhuang, Xijing
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [28] Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs
    Byttebier, Geert
    Belmans, Luc
    Alexander, Myriam
    Saxberg, Bo E. H.
    De Spiegeleer, Bart
    De Spiegeleer, Anton
    Devreker, Nick
    Van Praet, Jens T.
    Vanhove, Karolien
    Reybrouck, Reinhilde
    Wynendaele, Evelien
    Fedson, David S.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (09) : 2841 - 2850
  • [29] Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) may be safe for COVID-19 patients
    Wenjun Wang
    Xiaohui Zhao
    Wei Wei
    Weiwang Fan
    Kai Gao
    Shengxiu He
    Xijing Zhuang
    BMC Infectious Diseases, 21
  • [30] Dual blockade of the renin-angiotensin system with angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs)
    Ritter, J. M.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (03) : 313 - 315
12345